Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (8)

1

Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system

enthalten in: Aging | 2021

von Liisborg, C. | Skov, V. | Kjær, L. | +2

2

Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis

enthalten in: Cancer medicine | 2018

von Mikkelsen, S. | Kjaer, L. | Bjørn, M. | +14

3

High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis

enthalten in: Leukemia research | 2011

von Hasselbalch, H. | Skov, V. | Larsen, T. | +5

4

Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis

enthalten in: European journal of haematology | 2011

von Skov, V. | Larsen, T. | Thomassen, M. | +5

5

New molecular markers within the chronic myeloproliferative disorders. I : the PRV-1 gene

enthalten in: Ugeskrift for laeger | 2006

von Larsen, T. | Pallisgaard, N. | Christensen, J. | +4

CommentIn: Ugeskr Laeger. 2006 Oct 30;168(44):3832; author reply 3832. - PMID 17131518

6

New molecular markers within the chronic myeloproliferative disorders. II : the JAK2 mutation

enthalten in: Ugeskrift for laeger | 2006

von Larsen, T. | Pallisgaard, N. | Christensen, J. | +4

7

Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders

enthalten in: European journal of haematology | 2003

von Jensen, M. | Holten-Andersen, M. | Riisbro, R. | +6

8

Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders

enthalten in: American journal of hematology | 2002

von Jensen, M. | de Nully Brown, P. | Thorsen, S. | +1

1
[1]